Finnish nasal-administered Covid vaccine to start trials late this year
The vaccine could potentially be on the market by 2025.
Source: yle.fi
Erkko Yl News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Erkko Yl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Erkko Yl Today - Breaking & Trending Today
EQS-News: CEVEC Pharmaceuticals GmbH: ROKOTE Laboratories licenses CEVEC's CAP® Ad Technology for vaccine manufacturing
EQS-News: CEVEC Pharmaceuticals GmbH / Key word(s): Agreement CEVEC Pharmaceuticals GmbH: ROKOTE Laboratories licenses CEVEC’s CAP® Ad Technology for vaccine manufacturing 20.09.2022 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. ROKOTE Laboratories licen...
Source: boersennews.de
EQS-News: CEVEC Pharmaceuticals GmbH: ROKOTE Laboratories licenses CEVEC's CAP Ad Technology for vaccine manufacturing
EQS-News: CEVEC Pharmaceuticals GmbH / Key word(s): Agreement CEVEC Pharmaceuticals GmbH: ROKOTE Laboratories licenses CEVEC's CAP Ad Technology for vaccine manufacturing 20.09.2022
Source: finanznachrichten.de
Rokote Laboratories selects Exothera for GMP manufacturing of its second-generation coronavirus vaccine FINCoVac 2.0.
/PRNewswire/ -- Rokote Laboratories Finland Ltd., a vaccine development company focussing on a second-generation COVID-19 vaccine, and Exothera S.A. will...
Source: prnewswire.com